D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Microbiology D-index 63 Citations 14,734 234 World Ranking 929 National Ranking 37
Medicine D-index 72 Citations 17,848 313 World Ranking 14390 National Ranking 519

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Acquired immunodeficiency syndrome
  • Disease

Hepatitis C, Hepatitis C virus, Internal medicine, Immunology and Virology are his primary areas of study. His studies deal with areas such as Epidemiology, Cohort study, Incidence, Intensive care medicine and Substance abuse as well as Hepatitis C. His work deals with themes such as Viral disease, Disease burden and Developed country, which intersect with Hepatitis C virus.

His Internal medicine course of study focuses on Ribavirin and Alpha interferon. His Immunology study incorporates themes from Pharmacotherapy and Disease. His research investigates the connection between Virology and topics such as Reimbursement that intersect with problems in Paritaprevir, Ritonavir, Dasabuvir and Hepatitis.

His most cited work include:

  • Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study (981 citations)
  • Epidemiology and natural history of HCV infection (659 citations)
  • Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review (481 citations)

What are the main themes of his work throughout his whole career to date?

His scientific interests lie mostly in Hepatitis C virus, Hepatitis C, Virology, Internal medicine and Immunology. The Hepatitis C virus study combines topics in areas such as Incidence, Viral load, Drug and Cohort. His studies in Incidence integrate themes in fields like Transmission and Environmental health.

His Hepatitis C study combines topics in areas such as Odds ratio, Epidemiology, Family medicine, Liver disease and Prospective cohort study. His study focuses on the intersection of Internal medicine and fields such as Ribavirin with connections in the field of Alpha interferon. Jason Grebely studies Immunology, namely Coinfection.

He most often published in these fields:

  • Hepatitis C virus (52.39%)
  • Hepatitis C (48.67%)
  • Virology (35.37%)

What were the highlights of his more recent work (between 2018-2021)?

  • Hepatitis C virus (52.39%)
  • Hepatitis C (48.67%)
  • Internal medicine (35.11%)

In recent papers he was focusing on the following fields of study:

Jason Grebely spends much of his time researching Hepatitis C virus, Hepatitis C, Internal medicine, Environmental health and Family medicine. His Hepatitis C virus research is under the purview of Virology. His Hepatitis C study also includes

  • Hepatitis and related Viral hepatitis,
  • Harm reduction which intersects with area such as Psychological intervention.

His study in Internal medicine is interdisciplinary in nature, drawing from both Pibrentasvir, Glecaprevir, Drug and Sofosbuvir. His Environmental health research is multidisciplinary, relying on both Meta-analysis and Systematic review. His Family medicine research is multidisciplinary, incorporating perspectives in Addiction medicine and Phlebotomy.

Between 2018 and 2021, his most popular works were:

  • Global, regional, and country‐level estimates of hepatitis C infection among people who have recently injected drugs (85 citations)
  • Global patterns of opioid use and dependence: harms to populations, interventions, and future action. (81 citations)
  • Association between rapid utilisation of direct hepatitis C antivirals and decline in the prevalence of viremia among people who inject drugs in Australia (43 citations)

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study

Sarah Blach;Stefan Zeuzem;Michael Manns;Ibrahim Altraif.
The Lancet Gastroenterology & Hepatology (2017)

1254 Citations

Epidemiology and natural history of HCV infection

Behzad Hajarizadeh;Jason Grebely;Gregory J. Dore.
Nature Reviews Gastroenterology & Hepatology (2013)

1029 Citations

Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review

Louisa Degenhardt;Amy Peacock;Samantha Colledge;Janni Leung.
The Lancet Global Health (2017)

649 Citations

Hepatitis C Virus Treatment for Prevention Among People Who Inject Drugs: Modeling Treatment Scale-Up in the Age of Direct-Acting Antivirals

Natasha K. Martin;Peter Vickerman;Jason Grebely;Margaret Hellard.
Hepatology (2013)

528 Citations

Restrictions for Medicaid Reimbursement of Sofosbuvir for the Treatment of Hepatitis C Virus Infection in the United States.

Soumitri Barua;Robert Greenwald;Jason Grebely;Gregory J. Dore.
Annals of Internal Medicine (2015)

396 Citations

The effects of female sex, viral genotype, and IL28B genotype on spontaneous clearance of acute hepatitis C virus infection

Jason Grebely;Kimberly A Page;Rachel Sacks-Davis;Martin Schim van der Loeff.
Hepatology (2014)

377 Citations

Global statistics on alcohol, tobacco and illicit drug use: 2017 status report

Amy Peacock;Amy Peacock;Janni Leung;Sarah Larney;Sarah Larney;Samantha Colledge.
Addiction (2018)

357 Citations

Treatment of Hepatitis C virus infection among people who are actively injecting drugs: a systematic review and meta-analysis

Esther J Aspinall;Stephen Corson;Joseph S Doyle;Joseph S Doyle;Joseph S Doyle;Jason Grebely.
Clinical Infectious Diseases (2013)

350 Citations

Hepatocellular carcinoma risk following direct-acting antiviral HCV therapy: A systematic review, meta-analyses, and meta-regression

Reem Waziry;Behzad Hajarizadeh;Jason Grebely;Janaki Amin.
Journal of Hepatology (2017)

349 Citations

Elbasvir-Grazoprevir to Treat Hepatitis C Virus Infection in Persons Receiving Opioid Agonist Therapy: A Randomized Trial

Gregory J. Dore;Frederick Altice;Alain H. Litwin;Olav Dalgard.
Annals of Internal Medicine (2016)

316 Citations

Editorial Boards

Journal of Hepatology
(Impact Factor: 30.083)

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Jason Grebely

Margaret Hellard

Margaret Hellard

Burnet Institute

Publications: 161

Peter Vickerman

Peter Vickerman

University of Bristol

Publications: 100

Matthew Hickman

Matthew Hickman

University of Bristol

Publications: 83

Gregory J. Dore

Gregory J. Dore

UNSW Sydney

Publications: 67

Jeffrey V. Lazarus

Jeffrey V. Lazarus

University of Barcelona

Publications: 61

Lisa Maher

Lisa Maher

UNSW Sydney

Publications: 60

Marina B. Klein

Marina B. Klein

McGill University Health Centre

Publications: 51

Andrew R. Lloyd

Andrew R. Lloyd

UNSW Sydney

Publications: 49

Jacob George

Jacob George

University of Sydney

Publications: 47

Stefan Zeuzem

Stefan Zeuzem

Goethe University Frankfurt

Publications: 46

Maria Prins

Maria Prins

University of Amsterdam

Publications: 45

Zobair M. Younossi

Zobair M. Younossi

Inova Health System

Publications: 44

Heiner Wedemeyer

Heiner Wedemeyer

Hannover Medical School

Publications: 44

Mark Stoove

Mark Stoove

Burnet Institute

Publications: 38

Frederick L. Altice

Frederick L. Altice

Yale University

Publications: 37

Shruti H. Mehta

Shruti H. Mehta

Johns Hopkins University

Publications: 37

Trending Scientists

Robert M. Clark

Robert M. Clark

Environmental Protection Agency

Xuzhou Yan

Xuzhou Yan

Shanghai Jiao Tong University

Jong Hyun Ahn

Jong Hyun Ahn

Yonsei University

Pertti Sistonen

Pertti Sistonen

Finnish Red Cross

Pieter J. de Jong

Pieter J. de Jong

UCSF Benioff Children's Hospital

Trina A. Schroer

Trina A. Schroer

Johns Hopkins University

Yusuke Hiraku

Yusuke Hiraku

University of Fukui

Sucharit Bhakdi

Sucharit Bhakdi

Kiel University

Benjamin H. Passey

Benjamin H. Passey

University of Michigan–Ann Arbor

Tibor Hajszan

Tibor Hajszan

Biological Research Centre

Kurt P. Spindler

Kurt P. Spindler

Cleveland Clinic

Judith E. Adams

Judith E. Adams

University of Manchester

Helen Vlassara

Helen Vlassara

Icahn School of Medicine at Mount Sinai

Mark S. Cohen

Mark S. Cohen

University of Michigan–Ann Arbor

Kathryn M. Neckerman

Kathryn M. Neckerman

Columbia University

Reina H. Maruyama

Reina H. Maruyama

Yale University

Something went wrong. Please try again later.